Apitope Announces Positive Results with Novel Treatment for Graves' Disease

Phase I data show early efficacy in the majority of patients and a very favourable safety profile HASSELT, Belgium and CHEPSTOW, Wales, April 16, 2018 -- (Healthcare Sales &Marketing Network) -- Apitope, a clinical stage biotech company developing pot... Biopharmaceuticals Apitope, Graves' Disease, Multiple Sclerosis, autoimmune disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

Publication date: May 2019Source: Molecular Immunology, Volume 109Author(s): Hongxing Shen, Lewis Zhichang ShiAbstractIL-17-producing TH17 cells have been associated with autoimmune diseases such as multiple sclerosis (MS), psoriasis, Crohn’s disease, and ulcerative colitis (Han et al., 2015), many of which lack effective therapies. Identifying effective approaches to selectively suppress TH17 cell development and function represents a legitimate strategy to cure these autoimmune disorders. TH17 cell differentiation requires rewiring of their metabolic program, transition from the oxidative phosphorylation-dominant c...
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research
CD40/CD154-interaction is critical in the development of Experimental Autoimmune Encephalomyelitis (EAE; mouse model of Multiple Sclerosis). Culprit CD4+CD40+ T cells drive a more severe form of EAE than conventional CD4 T cells. Blocking CD40/CD154-interaction with CD154-antibody prevents or ameliorates disease but had thrombotic complications in clinical trials. We targeted CD40 using a CD154-sequence based peptide. Peptides in human therapeutics demonstrate good safety. A small peptide, KGYY6, ameliorates EAE when given as pretreatment or at first symptoms.
Source: Journal of Neuroimmunology - Category: Allergy & Immunology Authors: Source Type: research
AbstractMultiple sclerosis (MS) as a chronic autoimmune disease of the central nervous system (CNS) has been associated with dysregulation of several genes including miRNAs. In the present study, we assessed transcript levels of seven miRNAs (miR-96-5p, miR-211-5p, miR-15a, miR-34a-5p, miR-204-5p, miR-501-5p, and miR-524-5p) in the peripheral blood of MS patients compared with healthy subjects in association with response to fingolimod treatment. Expression levels of miR-211-5p and miR-34a-5p were significantly decreased in MS patients compared with healthy subjects (P values of 0.002 and 0.47). While subgroup analysis sho...
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
ConclusionThe study of genes involved in the VD signaling pathway in families that include more than one patient with MS did not identify any variants that could explain the presence of the disease, suggesting that VD metabolism could probably play a role in MS more as an environmental factor rather than as a genetic factor. Our study also supports the analysis of cases and unaffected individuals within families in order to determine the influence of genetic factors.
Source: Brain and Behavior - Category: Neurology Authors: Tags: ORIGINAL RESEARCH Source Type: research
We report here the findings of our study of the CNS demyelination process using immune-induced [experimental autoimmune encephalomyelitis (EAE)] and chemical-induced [cuprizone (CPZ)] mouse models of demyelination. We found that necroptosis, a receptor-interacting protein 3...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
Abstract It is well recognized that variation in the geographical distribution of prevalence of multiple sclerosis (MS) exists: increasing the latitude its prevalence increases as well, but the underlying causes of such dissimilarity still remained elusive as of today. Currently, the most accredited hypothesis is that the closer to the equator the more pronounced is the amount of sunlight which, in turn, increases the production of vitamin D. Cholecalciferol is indeed deficient in MS patients, but this factor does not explain by itself the etiopathogenesis of the disease. In the present study, to search for a patt...
Source: Amino Acids - Category: Biochemistry Authors: Tags: Amino Acids Source Type: research
Authors: Martellosio JP, Leleu X, Roblot P, Martin M, Puyade M Abstract Serum free light chains (sFLC) assay is an important marker in plasma cell dyscrasia. It is thus recommended for the diagnosis of monoclonal gammopathy, together with serum protein electrophoresis and immunofixation. sFLC assay has also a prognostic value and is a criterion for treatment response and relapse of some monoclonal gammopathies. Three assays are currently available in France, the gold standard being the Freelite® assay, the two others requiring further validation. These three assays are not interchangeable during patient's follo...
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research
Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) in which the immune system damages the protective insulation surrounding the nerve fibers that project from neurons. A hallmark of MS and its animal model, experimental autoimmune encephalomyelitis (EAE), is autoimmunity against proteins of the myelin sheath. Most studies in this field have focused on the roles of CD4+ T lymphocytes, which form part of the adaptive immune system as both mediators and regulators in disease pathogenesis. Consequently, the treatments for MS often target the inflammatory CD4+ T-cell ...
Source: Cellular and Molecular Immunology - Category: Molecular Biology Authors: Tags: Cell Mol Immunol Source Type: research
ConclusionsOur results discover relevant caveats in the currently used methods of immunofluorescence analysis. The provided step-by-step instructions and open-source code are intended to serve as a framework for sensitive, unbiased immunofluorescence analysis of tissue sections in translational research.
Source: Journal of Neuroscience Methods - Category: Neuroscience Source Type: research
AbstractMucosal tolerance refers to the physiological process by which exposure of proteins to the mucosal surface preferentially induces tolerance. The route of mucosal administration can determine the type of regulatory T (Treg) cells induced, with the oral route inducing transforming growth factor ‐β‐producing Treg cells and the nasal route inducing interleukin‐10‐secreting Treg cells. Previous studies of oral tolerance to autoantigens in humans, including patients with multiple sclerosis, rheumatoid arthritis and diabetes, led to mixed results and negative phase III trials, althoug h oral immunotherap...
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Tags: Review Article Source Type: research
More News: Autoimmune Disease | Belgium Health | Biotechnology | Marketing | Multiple Sclerosis | Pharmaceuticals | Wales Health